Transenterix Inc.'s Senhance recently scrubbed in, so to speak, to lend its robotic hands to a gynecologic surgeon in Italy during a major cervical cancer procedure. It was the first time the company's recently re-branded surgical robotic system has been used during a radical hysterectomy and, if the surgeon's feedback is any indication, it probably won't be the last time the Senhance is involved with a complex gynecologic oncology case.